Participants
| Role | Name | HCID | Charge |
|---|
| Reactant | Hydrochloric Acid | HCID 313 | — |
| Reactant | HCID 25164163 | HCID 25164163 | — |
| Solvent | Tetrahydrofuran | HCID 8028 | — |
| Product | HCID 25255743 | HCID 25255743 | — |
Reaction Steps
250 mg ethyl 4-[4-[(2R)-3-[4-amino-3-chloro-5-(trifluoromethyl)phenyl]-1-oxo-2-[[[4-(1,2,4,5-tetrahydro-2-oxo-3H-1,3-benzodiazepin-3-yl)-1-piperidinyl]carbonyl]oxy]propyl]-1-piperazinyl]-piperidine-1-acetate (0.316 mmol) of are dissolved in 2.5 ml of tetrahydrofuran at ambient temperature. The solution is heated to 80° C. and combined with 98 μL isopropanolic hydrochloric acid (3.2 Mol/l, 0.316 mmol). The temperature is lowered by 5° C. every 30 minutes. The suspension formed is stirred for 12 hours at ambient temperature. The solid formed is filtered off, washed with a little tetrahydrofuran and dried for 12 hours at 35° C.
Provenance & Evidence
| DOI | 10.6084/m9.figshare.5104873.v1 |
|---|
| Patent number | US08551987B2 |
|---|
| Source dataset | uspto-grants-2013_10 |
|---|
| ORD ID | ord-567cc30ff0854b1a9b899d22735f5728 |
|---|
| Source note | uspto-grants-2013_10 |
|---|